These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2104832)

  • 1. Binding of human factor VIII to phospholipid vesicles.
    Gilbert GE; Furie BC; Furie B
    J Biol Chem; 1990 Jan; 265(2):815-22. PubMed ID: 2104832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.
    Spaargaren J; Giesen PL; Janssen MP; Voorberg J; Willems GM; van Mourik JA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):539-45. PubMed ID: 7654192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane binding kinetics of factor VIII indicate a complex binding process.
    Bardelle C; Furie B; Furie BC; Gilbert GE
    J Biol Chem; 1993 Apr; 268(12):8815-24. PubMed ID: 8473326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid.
    Lollar P; Knutson GJ; Fass DN
    Blood; 1984 Jun; 63(6):1303-8. PubMed ID: 6426549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactadherin binds selectively to membranes containing phosphatidyl-L-serine and increased curvature.
    Shi J; Heegaard CW; Rasmussen JT; Gilbert GE
    Biochim Biophys Acta; 2004 Nov; 1667(1):82-90. PubMed ID: 15533308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of phosphatidylserine-containing membrane binding sites for factor VIII. Studies with model membranes supported by glass microspheres (lipospheres).
    Gilbert GE; Drinkwater D; Barter S; Clouse SB
    J Biol Chem; 1992 Aug; 267(22):15861-8. PubMed ID: 1639816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preparation and phospholipid binding property of the C2 domain of human factor VIII.
    Takeshima K; Smith C; Tait J; Fujikawa K
    Thromb Haemost; 2003 May; 89(5):788-94. PubMed ID: 12719774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles.
    Duffy EJ; Parker ET; Mutucumarana VP; Johnson AE; Lollar P
    J Biol Chem; 1992 Aug; 267(24):17006-11. PubMed ID: 1512239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles.
    Andersson LO; Brown JE
    Biochem J; 1981 Oct; 200(1):161-7. PubMed ID: 6800356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.
    Ortel TL; Devore-Carter D; Quinn-Allen M; Kane WH
    J Biol Chem; 1992 Feb; 267(6):4189-98. PubMed ID: 1740460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of factor VIII by thrombin increases its affinity for binding to synthetic phospholipid membranes and activated platelets.
    Saenko EL; Scandella D; Yakhyaev AV; Greco NJ
    J Biol Chem; 1998 Oct; 273(43):27918-26. PubMed ID: 9774404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes.
    Saenko E; Sarafanov A; Greco N; Shima M; Loster K; Schwinn H; Josic D
    J Chromatogr A; 1999 Aug; 852(1):59-71. PubMed ID: 10480230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine.
    Foster PA; Fulcher CA; Houghten RA; Zimmerman TS
    Blood; 1990 May; 75(10):1999-2004. PubMed ID: 2110840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the properties of phospholipid surfaces formed on HPA and L1 biosensor chips for the binding of the coagulation factor VIII.
    Saenko E; Sarafanov A; Ananyeva N; Behre E; Shima M; Schwinn H; Josić D
    J Chromatogr A; 2001 Jun; 921(1):49-56. PubMed ID: 11461013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.
    London F; Ahmad SS; Walsh PN
    Biochemistry; 1996 Dec; 35(51):16886-97. PubMed ID: 8988028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family.
    Tait JF; Gibson D; Fujikawa K
    J Biol Chem; 1989 May; 264(14):7944-9. PubMed ID: 2524476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human factor VIII procoagulant activity and phospholipid interaction.
    Lajmanovich A; Hudry-Clergeon G; Freyssinet JM; Marguerie G
    Biochim Biophys Acta; 1981 Nov; 678(1):132-6. PubMed ID: 6796129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of factor VIII with phospholipids: role of composition and negative charge.
    Kemball-Cook G; Barrowcliffe TW
    Thromb Res; 1992 Jul; 67(1):57-71. PubMed ID: 1440515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid binding of annexin V: effects of calcium and membrane phosphatidylserine content.
    Tait JF; Gibson D
    Arch Biochem Biophys; 1992 Oct; 298(1):187-91. PubMed ID: 1388011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.